Immunization News and Research

RSS
Mutations in the SARS-CoV-2 receptor-binding domain analyzed

Mutations in the SARS-CoV-2 receptor-binding domain analyzed

Why even presidential pressure might not get more vaccine to market faster

Why even presidential pressure might not get more vaccine to market faster

Accelerating vaccine rollout may provide greatest reduction in COVID-19 mortality

Accelerating vaccine rollout may provide greatest reduction in COVID-19 mortality

Recombinant SARS-CoV-2 protein vaccine less immunogenic but more antigenic than expected

Recombinant SARS-CoV-2 protein vaccine less immunogenic but more antigenic than expected

Herd immunity to SARS-CoV-2 may not be achievable with current vaccines

Herd immunity to SARS-CoV-2 may not be achievable with current vaccines

Experts provide overview of deaths reported in Europe following BNT162b2 vaccination

Experts provide overview of deaths reported in Europe following BNT162b2 vaccination

First-ever systematic review to understand geographic factors that affect HPV vaccination rates

First-ever systematic review to understand geographic factors that affect HPV vaccination rates

COVID-19, influenza and suicide are responsible for deaths of ICE detainees

COVID-19, influenza and suicide are responsible for deaths of ICE detainees

Biden’s covid challenge: 100 million vaccinations in the first 100 days. It won’t be easy.

Biden’s covid challenge: 100 million vaccinations in the first 100 days. It won’t be easy.

World Health Assembly calls for urgent action on prevention and control of meningitis

World Health Assembly calls for urgent action on prevention and control of meningitis

International health organizations establish global Ebola vaccine stockpile

International health organizations establish global Ebola vaccine stockpile

Closed SARS-CoV-2 spikes could be a valuable component of future vaccines

Closed SARS-CoV-2 spikes could be a valuable component of future vaccines

A high-temperature tolerant SARS-CoV-2 derived immunogen as a potential vaccine candidate

A high-temperature tolerant SARS-CoV-2 derived immunogen as a potential vaccine candidate

Analysis supports phase 3 trials of Johnson & Johnson's COVID-19 vaccine

Analysis supports phase 3 trials of Johnson & Johnson's COVID-19 vaccine

Geography is destiny: Dentists’ access to Covid shots depends on where they live

Geography is destiny: Dentists’ access to Covid shots depends on where they live

Study compares acceptance of HPV vaccine and meningococcal vaccine

Study compares acceptance of HPV vaccine and meningococcal vaccine

New technology could protect against different coronavirus variants

New technology could protect against different coronavirus variants

Will the Pfizer–BioNTech vaccine be effective against the new N501Y SARS-CoV-2 variant?

Will the Pfizer–BioNTech vaccine be effective against the new N501Y SARS-CoV-2 variant?

Study supports continuing phase 3 trials of Ad26.COV2.S SARS-CoV-2 vaccine

Study supports continuing phase 3 trials of Ad26.COV2.S SARS-CoV-2 vaccine

Is your covid vaccine venue prepared to handle rare, life-threatening reactions?

Is your covid vaccine venue prepared to handle rare, life-threatening reactions?